Clinical trial for Diabetes Mellitus, Type 2
Official title Phenotypic and Genotypic Characterization of Patients With Dysmetabolism in Greenland
ClinicalTrials.gov ID: NCT06264427
What this study is testing
What is Whole genome sequencing?
An investigational genetic test being studied to help tailor diabetes treatment for people with type 2 diabetes in Greenland.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The study wants to see if specific genetic diabetes variants affect the risk of complications, whether genetic testing can help personalize care, and how common sleep apnea is in high‑risk Greenlanders.
- Who it's for
- Adults in Greenland who have type 2 diabetes, severe obesity, or sleep apnea and are receiving care at Steno Diabetes Center Greenland.
- What's involved
- Participants will fill out quality‑of‑life and sleepiness questionnaires, have a heart‑autonomic test, a physical exam, and a nasal airflow test, and give a blood sample for full genome sequencing.
- Time commitment
- The study lasts about a few weeks, with a single visit that includes the tests and questionnaires described above.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Type 2 diabetes and/or morbid obesity (BMI \>40)
- Over 18 years old
You likely can't join if
- Does not speak either English, Danish or Greenlandic
The study team makes the final eligibility decision.
Where it is enrolling
- Nuuk, Sermersooq, Greenland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Nuuk, Sermersooq, Greenland. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.